NanoRepro AG
NN6
Company Profile
Business description
NanoRepro AG is engaged in the development, manufacturing, and distribution of CE-certified rapid diagnostic tests (self-tests) and food supplements for both, home and professional use.
Contact
Untergasse 8
Marburg35037
DEUT: +49 6421951449
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
22
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,631.50 | 42.70 | 0.50% |
| CAC 40 | 7,845.29 | 17.16 | 0.22% |
| DAX 40 | 24,272.13 | 244.48 | 1.02% |
| Dow JONES (US) | 42,122.95 | 519.88 | 1.25% |
| FTSE 100 | 8,788.90 | 70.93 | 0.81% |
| HKSE | 23,381.99 | 99.66 | 0.43% |
| NASDAQ | 19,109.07 | 371.87 | 1.98% |
| Nikkei 225 | 37,724.11 | 192.58 | 0.51% |
| NZX 50 Index | 12,582.33 | 35.11 | 0.28% |
| S&P 500 | 5,894.87 | 92.05 | 1.59% |
| S&P/ASX 200 | 8,407.60 | 46.60 | 0.56% |
| SSE Composite Index | 3,340.69 | 6.15 | -0.18% |